Results 101 to 110 of about 26,281 (176)

Oligoprogressive renal cell carcinoma: What is the role of surgery?

BJU International, Volume 138, Issue 2, Page 219-228, August 2026.
Objective To provide an overview of the biological mechanism and pattern of oligoprogression in renal cell carcinoma (RCC) and the most updated role of surgery in this setting, highlighting scientific gaps and informing future implications. Methods A non‐systematic search of PubMed/MEDLINE was performed in August 2025 including guidelines, reviews, and
Chiara Re, William H.J. Ince, Leo Bickley, James P. Blackmur, Mouhamad H. Ismail, Justicia Kyeremeh, Teele Kuusk, Eva Mendes Serrao, James O. Jones, Grant D. Stewart   +9 more
wiley   +1 more source

[18F]PSMA‐1007 PET–Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer

International Journal of Urology, Volume 33, Issue 8, August 2026.
ABSTRACT Objectives Prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) is a sensitive imaging modality for detecting recurrent prostate cancer following definitive local therapy. However, evidence on 18F‐labeled PSMA tracers in Japanese patients with biochemical recurrence (BCR) remains limited.
Koji Hatano, Tadashi Watabe, Takero Hirata, Masatoshi Konishi, Tomohiro Kanaki, Masaru Tani, Toshiki Oka, Yu Ishizuya, Takuji Hayashi, Yoshiyuki Yamamoto, Taigo Kato, Atsunari Kawashima, Kazutoshi Fujita, Motohide Uemura, Frederik L. Giesel, Norio Nonomura   +15 more
wiley   +1 more source

Association of recurrence patterns and outcome with HR and HER2 status in patients with resected brain metastases from breast cancer

International Journal of Cancer, Volume 159, Issue 2, Page 440-449, 15 July 2026.
What's new? While treatment strategies for solid brain metastases have been relatively uniform across cancer subtypes, tailored approaches are warranted. In this observational study, intracranial recurrences after microsurgical resection occurred significantly earlier and more frequently at distant sites in patients with triple‐negative breast cancer ...
Jonathan Weller, Sophie Katzendobler, Frederic Thiele, Anna Riesberg, Patrick N. Harter, Frederick Klauschen, Rachel Wuerstlein, Stephan Schoenecker, Montserrat Pazos Escudero, Robert Forbrig, Niklas Thon, Florian Ringel, Michael Weller, Emilie Le Rhun, Veit M. Stoecklein   +14 more
wiley   +1 more source

Salvage stereotactic body radiotherapy for post-prostatectomy recurrence: are we almost there? [PDF]

J Radiat Res
Chen Z, Tran VT, Matsuda M, Akita T, Marino K, Komiyama T, Onishi H.   +6 more
europepmc   +1 more source

Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanoma

International Journal of Cancer, Volume 159, Issue 2, Page 339-344, 15 July 2026.
What's new? Uveal melanoma is the most common primary intraocular cancer in adults, and up to half of patients develop metastatic disease, predominantly in the liver, where prognosis remains poor despite promising treatment options. In this study, the authors evaluated the safety and efficacy of administering systemic therapy within 40 days of liver ...
Patrick Kasteleiner, Gerd Grözinger, Jörg Schmehl, Lukas Flatz, Andrea Forschner   +4 more
wiley   +1 more source

Single-Fraction Stereotactic Body Radiotherapy for Early-Stage Lung Adenocarcinoma Within Atelectasis. [PDF]

Cureus
Daniels J, Mou B.
europepmc   +1 more source

Stereotactic body radiotherapy to the left lung in right lateral decubitus: A challenging case report. [PDF]

J Appl Clin Med Phys
Cammin J, Manuel E, Chen S, Rana Z, Ferris MJ.   +4 more
europepmc   +1 more source

Stereotactic Body Radiotherapy for Oligometastatic Disease in Melanoma Patients Receiving Immunotherapy: A Single-Center Retrospective Analysis. [PDF]

Cancers (Basel)
Lekić M, Kaučić H, Kosmina D, Prološčić I, Ursi G, Leipold V, Divošević S, Ilić MK, Schwarz K, Schwarz D, Vučinić D.   +10 more
europepmc   +1 more source

Stereotactic body radiotherapy combined with immunotherapy: a systematic review focus on timing and toxicity profile. [PDF]

Tech Innov Patient Support Radiat Oncol
Cattaneo CG, Chiloiro G, Romano A, Panza G, Galetto M, Nardini M, Placidi L, Gambacorta MA, Boldrini L.   +8 more
europepmc   +1 more source

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)

Frontiers in Oncology, 2021
Rupesh Kotecha, Rupesh Kotecha, Debnarayan Dutta, Rakesh Jalali, Alexander Muacevic   +4 more
doaj   +1 more source